NTRB
Price
$7.54
Change
-$0.64 (-7.82%)
Updated
Jun 5, 04:28 PM (EDT)
Capitalization
91.05M
27 days until earnings call
VRAX
Price
$0.97
Change
+$0.02 (+2.11%)
Updated
Jun 5, 04:56 PM (EDT)
Capitalization
4.12M
Interact to see
Advertisement

NTRB vs VRAX

Header iconNTRB vs VRAX Comparison
Open Charts NTRB vs VRAXBanner chart's image
Nutriband
Price$7.54
Change-$0.64 (-7.82%)
Volume$100
Capitalization91.05M
Virax Biolabs Group
Price$0.97
Change+$0.02 (+2.11%)
Volume$300
Capitalization4.12M
NTRB vs VRAX Comparison Chart
Loading...
NTRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NTRB vs. VRAX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTRB is a Hold and VRAX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (NTRB: $8.18 vs. VRAX: $0.95)
Brand notoriety: NTRB and VRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTRB: 142% vs. VRAX: 14%
Market capitalization -- NTRB: $91.05M vs. VRAX: $4.12M
NTRB [@Biotechnology] is valued at $91.05M. VRAX’s [@Biotechnology] market capitalization is $4.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTRB’s FA Score shows that 0 FA rating(s) are green whileVRAX’s FA Score has 1 green FA rating(s).

  • NTRB’s FA Score: 0 green, 5 red.
  • VRAX’s FA Score: 1 green, 4 red.
According to our system of comparison, both NTRB and VRAX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTRB’s TA Score shows that 6 TA indicator(s) are bullish while VRAX’s TA Score has 4 bullish TA indicator(s).

  • NTRB’s TA Score: 6 bullish, 4 bearish.
  • VRAX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, NTRB is a better buy in the short-term than VRAX.

Price Growth

NTRB (@Biotechnology) experienced а +29.64% price change this week, while VRAX (@Biotechnology) price change was -2.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +9.95%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

NTRB is expected to report earnings on Oct 01, 2025.

VRAX is expected to report earnings on Aug 12, 2022.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTRB($91M) has a higher market cap than VRAX($4.13M). NTRB YTD gains are higher at: 73.673 vs. VRAX (-57.778). VRAX (-6.43M) and NTRB (-6.52M) have comparable annual earnings (EBITDA) . VRAX has more cash in the bank: 7.29M vs. NTRB (5.7M). NTRB has less debt than VRAX: NTRB (200K) vs VRAX (380K). NTRB has higher revenues than VRAX: NTRB (2.02M) vs VRAX (84.9K).
NTRBVRAXNTRB / VRAX
Capitalization91M4.13M2,206%
EBITDA-6.52M-6.43M101%
Gain YTD73.673-57.778-128%
P/E RatioN/AN/A-
Revenue2.02M84.9K2,382%
Total Cash5.7M7.29M78%
Total Debt200K380K53%
FUNDAMENTALS RATINGS
NTRB: Fundamental Ratings
NTRB
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NTRBVRAX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 16 days ago
87%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
NTRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FTDR57.140.30
+0.53%
Frontdoor
RRX136.300.27
+0.20%
Regal Rexnord Corp
QH1.16N/A
-0.01%
Quhuo Limited
KLXE1.84-0.02
-1.08%
KLX Energy Services Holdings
CMPS4.52-0.07
-1.53%
COMPASS Pathways Plc

NTRB and

Correlation & Price change

A.I.dvisor tells us that NTRB and VRAX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NTRB and VRAX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRB
1D Price
Change %
NTRB100%
+6.10%
VRAX - NTRB
31%
Poorly correlated
-5.00%
NOXOF - NTRB
29%
Poorly correlated
N/A
SYRE - NTRB
27%
Poorly correlated
-0.30%
STOK - NTRB
27%
Poorly correlated
+0.37%
REPL - NTRB
26%
Poorly correlated
+0.62%
More